Early tests show that a new biologic is effective against serious infection.

Published Date: 26 Apr 2023

study participants included Janssen Biotech, Inc. and the NYU Grossman School of Medicine. have demonstrated in preliminary studies that a bioengineered drug candidate can prevent infection caused by the highly resistant bacterial species Staphylococcus aureus.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

2.

Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib

3.

In prostate cancer survivorship, sleep disturbances are underappreciated.

4.

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

5.

a cutting-edge cancer diagnostic tool.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot